Clinical Trial Update: Revlimid And Prednisone Followed By Revlimid, Melphalan And Prednisone In Multiple Myeloma Patients [Phase 2]

View source ↗

Summary

Phase 2 clinical trial update evaluating Revlimid (lenalidomide) and prednisone followed by Revlimid, melphalan, and prednisone in patients with multiple myelom…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Multiple Myeloma

Drugs mentioned

• Melphalan (Melphalan)
• PREDNISONE (Prednisone)
• Revlimid (lenalidomide)

Snippet

Sponsor: Fondazione EMN Italy Onlus | Conditions: Multiple Myeloma | Phase 2 | Status: COMPLETED